Skin Elements Raises $2.5M, Advances SE Formula Commercialisation

Quarterly Progress and Financial Strength

Skin Elements Limited (ASX, SKN), an Australian leader in natural antimicrobial biotechnology, has reported a robust quarter ending 31 December 2025. The company successfully completed a $2.5 million strategic placement, bolstering its financial position to accelerate growth and commercialisation efforts. This capital injection complements a $610,000 research and development rebate, underscoring the government's support for Skin Elements’ innovative biotechnology programs.

Despite a net operating cash outflow of $300,000 for the quarter, the company maintains a healthy cash balance of $1.73 million, providing nearly six quarters of runway. This financial footing is critical as Skin Elements prepares to transition its award-winning SE Formula biotechnology platform from development to market-ready products.

SE Formula Platform and Product Readiness

The SE Formula biotechnology platform, the result of two decades of research, underpins Skin Elements’ suite of natural, plant-based products. These include the Elizabeth Jane Natural Cosmetics, Soléo Organics sunscreen, PapayaActivs therapeutic skincare, SuprCuvr disinfectants, and ECO-Nurture agricultural biostimulants. All have completed phase three development, positioning them for imminent commercialisation or joint venture opportunities.

Notably, ECO-Nurture has undergone extensive field evaluation, with over 6,400 litres applied across 120 kiwifruit orchards in New Zealand over recent seasons. The product has demonstrated effective plant protection and productivity benefits without chemical residues, earning approval under Zespri’s Crop Allowed Other Compounds list. This endorsement from the world’s largest kiwifruit marketer signals strong commercial potential for ECO-Nurture in sustainable agriculture.

Commercial Adoption and Market Validation

SuprCuvr, Skin Elements’ 100% plant-based hospital-grade disinfectant, has secured adoption by Spotless for cleaning and disinfecting Melbourne’s suburban trains and stations. This contract, facilitated through Bunzl Victoria, highlights the product’s efficacy and regulatory approvals, including TGA listing in Australia and MPI registration in New Zealand.

Meanwhile, Soléo Organics sunscreen continues to garner accolades, being rated the top sunscreen globally by the Environmental Working Group and independently verified by Consumer NZ. These validations reinforce Skin Elements’ commitment to natural, effective products that meet stringent safety and performance standards.

Governance and Capital Management

In a strategic move to manage outstanding liabilities, Skin Elements settled $1 million in director and key management remuneration through equity issuance, approved by shareholders. Additionally, the conversion of options raised a further $750,000, enhancing liquidity. Operational expenditures remain focused on product manufacturing, R&D, marketing, and corporate functions, reflecting a balanced approach to scaling the business.

Executive Chairman Peter Malone expressed confidence in the company’s trajectory, emphasizing the strong foundation laid by recent funding and product validations. With commercial rollouts planned for 2026, Skin Elements is poised to capitalise on growing demand for natural, sustainable biotechnology solutions across healthcare and agriculture sectors.